Curcumin Recruiting Phase 3 Trials for Prostate Cancer Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02064673Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy
NCT03769766Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance